Both Companies Confirm Discussions As Market Weighs Potential Strategic Fit
Puig is in discussions with The Estée Lauder Companies regarding a potential merger of their businesses, both groups confirmed Monday.
“No final decision has been made and no agreement has been reached. Unless and until an agreement is reached, there can be no assurances regarding the deal or the terms,” Puig said in a statement.
The Estée Lauder Cos. echoed the position in a separate release issued after market close, noting it is in discussions regarding a potential business combination with Puig, but that no agreement has been reached and no assurances can be given on the outcome or terms.
News of the talks sent Estée Lauder shares down 7.7 percent to $79.29 on Monday, reflecting investor caution around the risks associated with integrating Puig’s business. The company ended the session with a market capitalization of $28.7 billion.
The potential deal has prompted renewed scrutiny of how the two portfolios might align. Estée Lauder’s stable includes Estée Lauder, Clinique, Deciem, Bobbi Brown, and Tom Ford, generating $14.7 billion in sales last year, down 3 percent.
Puig, meanwhile, operates across fragrance, fashion, makeup, and dermocosmetics, with brands including Rabanne, Carolina Herrera, Jean Paul Gaultier, Nina Ricci, Dries Van Noten, and Charlotte Tilbury, alongside niche fragrance houses such as Byredo, Penhaligon’s, and L’Artisan Parfumeur. The Spanish group reported net sales of 5.04 billion euros.
While both companies are family-founded, publicly listed, and now led by non-founding family members, their portfolios differ markedly. Puig remains heavily weighted toward fragrance, while Estée Lauder’s business is anchored in skin care and makeup.
The timing of the discussions follows Puig’s recent leadership transition, with Jose Manuel Albesa stepping into the role of chief executive officer, and Marc Puig moving to executive chairman after more than two decades leading the company.
A similar generational shift has unfolded at Estée Lauder, where the Lauder family stepped back from day-to-day management in 2024. Stéphane de La Faverie assumed the role of CEO in January 2025.
Strategically, the contrast in category strength could present a complementary opportunity. Puig holds three of the world’s top 10 fragrance brands — Rabanne, Carolina Herrera, and Jean Paul Gaultier — with its fragrance and fashion division accounting for 72 percent of net revenues, or 3.65 billion euros, in 2025.
Estée Lauder has long signaled ambitions in fragrance, though its exposure remains comparatively limited. The company wound down its Aramis & Designer Fragrances division in 2021, but has since renewed focus on the category, including the launch of La Maison des Parfum in France and investments such as Xinú, as well as licensing partnerships with Balmain.
Industry sources indicate that Puig’s fragrance expertise has been a longstanding point of interest for Estée Lauder.
Another area of appeal is Puig’s ownership of Charlotte Tilbury, which has driven growth in the group’s makeup category. Puig’s fourth-quarter 2025 sales rose 6.2 percent on a reported basis and 9.8 percent like-for-like, supported by the brand’s performance, which the company recently described as “exceptional.”
Makeup accounted for 17 percent of Puig’s sales in 2025, with Charlotte Tilbury as the primary contributor. The brand ranks first in prestige makeup in the U.K. and third in the U.S., with significant room for further distribution expansion.
For Estée Lauder, makeup remains a weaker point, with net sales declining 1 percent in the second quarter, driven by softness at the Estée Lauder brand, partially offset by MAC.
A merger could also offer Puig greater scale in the Americas, which represented 35 percent of its net sales last year, while strengthening its smaller skin care division, currently accounting for 11 percent of revenue.
At the same time, a combined entity would be better positioned to compete against L’Oréal, which has raised the competitive stakes through its long-term partnership with Kering in beauty and wellness.
Estée Lauder has faced sustained pressure since the pandemic, grappling with overexposure to China and travel retail, alongside a slower-than-expected recovery in the U.S. market.
Under de La Faverie, the company has been executing its Beauty Reimagined strategy and Profit Recovery and Growth Plan, though recent earnings fell short of some investor expectations, with concerns also lingering around tariff headwinds expected to impact fiscal 2026 profitability by approximately $100 million.
Shares of Estée Lauder are down 15 percent year-to-date.
Puig, for its part, went public in May 2024 in what was Europe’s largest IPO of the year and Spain’s biggest since 2015, valuing the company at 13.9 billion euros. Despite strong initial demand, with the offering multiple times oversubscribed, its stock has since declined 36 percent, closing up 3.6 percent on Monday at $15.57.